Why the study?
Fat accumulation in the liver and pancreas are manifestations of metabolic syndrome linked to inflammation, prompting investigation into whether CT-estimated NAFLD and NAFPD affect acute pancreatitis development.
Are NAFLD and NAFPD associated with the development of acute pancreatitis in patients presenting with abdominal pain?
Are NAFLD and NAFPD associated with the development of acute pancreatitis in patients presenting with abdominal pain?
Fat accumulation in the liver and pancreas (NAFLD and NAFPD), along with impaired glucose metabolism, are associated with an increased risk of acute pancreatitis.
NAFLD and NAFPD may indicate higher acute pancreatitis risk in metabolic patients; leaves open causality and needs prospective confirmation.
No takes yet. Share an insight, caveat, or question.
Ahbab et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: